| Issuer | % of Class | Filed |
|---|---|---|
|
Cyclerion Therapeutics, Inc.
13D/A
Amendment 8
CYCN · 23255M204
|
19.4% |
7/20/2026
Event 7/16/2026
|
|
Cyclerion Therapeutics, Inc.
13D/A
Amendment 7
CYCN · 23255M204
|
27.9% |
3/28/2025
Event 3/25/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.